EICHORCondition: Relapsed/Refractory Multiple Myeloma · Sponsor: Ichnos Sciences SA
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This study is a first-in-human, Phase 1, open-label study that will evaluate safety and anti-myeloma activity of ISB 2001 in participants with relapsed/refractory multiple myeloma (R/R MM).
This description comes directly from the study's public registry record.
Ichnos Sciences Clinical Trials Administrator · (315) 583-1249 · clinicaltrials@ichnossciences.com
Always discuss trial participation with your own doctor first.
| Standford Cancer Institute | Palo Alto, California, United States | Recruiting |
| Sylvester Cancer Center | Miami, Florida, United States | Active Not Recruiting |
| Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| University of Chicago Medical Center | Chicago, Illinois, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Recruiting |
| University of North Carolina | Chapel Hill, North Carolina, United States | Recruiting |
| Tennessee Oncology | Nashville, Tennessee, United States | Active Not Recruiting |
| Virginia Commonwealth University (VCU) | Richmond, Virginia, United States | Active Not Recruiting |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Recruiting |
| Concord Hospital | Concord, New South Wales, Australia | Recruiting |
| Pindara Private Hospital | Benowa, Queensland, Australia | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05862012